Market heard on the street Biotech Company Shows Its Vaccine Platform Will End the Pandemic
Tag: mRNA
Moderna’s RSV Vaccine Reduces Risk of Respiratory Diseases, Study Finds
Health The company says the experimental shot was 83.7% effective against lower-respiratory diseases caused by RSV
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 Vaccine
WSJ News Exclusive Health Commercial value similar to Pfizer’s plans after government contract ends
Corporate Insiders Aren’t Betting on a Market Rebound
Market shares The recent market downturn has driven down stock prices, but the officers and directors…
Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon
U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron,…
Latest Covid Boosters Are Set to Roll Out Before Human Testing Is Completed
The Food and Drug Administration is expected to authorize new Covid-19 booster shots this week without…
Moderna Sues Pfizer and BioNTech, Alleging Infringement of MRNA Patents
Moderna Inc. sued rival Covid-19 vaccine makers Pfizer Inc. and BioNTech SE, alleging that the companies’…
Moderna suing Pfizer over patent for ‘foundational’ COVID-19 mRNA vaccine – National | Globalnews.ca
Moderna is suing Pfizer and its biotech partner BioNTech for allegedly infringing on the “foundational” patent…
Moderna Asks FDA to OK Updated Covid-19 Shot
Moderna Inc. has asked U.S. regulators to authorize a new version of its Covid-19 vaccine that…